Health and Healthcare

Thursday's Top Biotech and Medical Stocks

From BioHealth Investor

Biotechnology

SHEFFIELD PHARMACTLS [SFPH.OB] +34.33%
IMMTECH PHARM INC [IMM] +19.09%
CYTORI THERAPEUTICS [CYTX] +9.96%
VERNALIS PLC ADR [VNLS] +9.09%
EMERGENT BIOSOLUTION [EBS] +5.94%

Diagnostic Substances

EPIX PHARMACEUTICALS [EPIX] +7.11%
SYNOVICS PHARMACEUTL [SYVC.OB] +6.25%
MONOGRAM BIOSCIENCES [MGRM] +2.96%
ORCHID CELLMARK INC [ORCH] +2.42%
EZ EM INC [EZEM] +2.39%

Drug Delivery

DELCATH SYSTEMS INC [DCTH] +21.78%
GENEREX BIOTECH CORP [GNBT] +8.00%
QUIGLEY CORP THE [QGLY] +5.83%
IOMED INC [IOX] +3.43%
BIOPROGRESS PLC [BPRG] +1.14%

Drug Manufacturers

ALEXZA PHARMACEUTICA [ALXA] +25.38%
AP PHARMA INC [APPA] +8.93%
INYX INC [IYXI.OB] +5.24%
CARDIOME PHARMA NEW [CRME] +3.93%
LIGAND PHARM CMN STK [LGND] +3.84%

Medical Appliances & Equipment

SPECTRASCIENCE NEW [SCIE.OB] +10.00%
SIGNALIFE INC [SGN] +9.24%
ATS MEDICAL INC [ATSI] +8.70%
BSD MEDICAL CORP [BSM] +8.24%
STEREOTAXIS, INC. [STXS] +6.31%

Medical Instruments & Supplies

VYTERIS HOLDINGS NV [VYHN.OB] +8.51%
PROTHERICS PLC [PTIL] +7.76%
CPC OF AMERICA INC [CPCF.OB] +7.22%
LEMAITRE VASCULAR [LMAT] +5.82%
THORATEC CORP [THOR] +3.83%

Medical Laboratories & Research

BIO-REFERENCE LAB [BRLI] +4.66%
BIO-IMAGING TECH [BITI] +1.56%
PSYCHEMEDICS NEW [PMD] +0.89%
NATL DENTEX CP [NADX] +0.79%
LABORATORY CORP NEW [LH] +0.14%

http://www.biohealthinvestor.com/

Take This Retirement Quiz To Get Matched With A Financial Advisor (Sponsored)

Take the quiz below to get matched with a financial advisor today.

Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.

Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future

Take the retirement quiz right here.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.